ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $37M

      Shares

      132k

      % of Portfolio

      0.63%

      Average Buy Price

      $297

      Avg closing price
      Price range

      11 Jefferies Group AMGEN Trades

      Jefferies Group acquired 132k AMGEN shares worth $37M. That's 0.63% of their equity portfolio (39th largest holding). The first AMGEN trade was made in Q4 2022. Since then Jefferies Group bought shares four more times and sold shares on six occasions. The investor's estimated purchase price is $39.2M, resulting in a loss of 5.6%.

      Avg closing price
      Price range
      Increased shares by 37.6% (+36.1k shares) Q2 2025
      Avg closing price $283.16
      Price range $262.28 - $309.85
      Sold 30.6% shares (-42.4k shares) Q1 2025
      Avg closing price $294.37
      Price range $258.59 - $327.36
      Sold 65.8% shares (-266k shares) Q4 2024
      Avg closing price $295.60
      Price range $259.30 - $328.35
      Increased shares by 403.1% (+324k shares) Q3 2024
      Avg closing price $326.94
      Price range $309.38 - $337.38
      Sold 3.7% shares (-3.08k shares) Q2 2024
      Avg closing price $293.78
      Price range $262.75 - $319.31
      Sold 52.5% shares (-92.2k shares) Q1 2024
      Avg closing price $292.61
      Price range $268.87 - $324.56
      Increased shares by 591.2% (+150k shares) Q4 2023
      Avg closing price $272.47
      Price range $255.70 - $288.46
      Sold 29.5% shares (-10.6k shares) Q3 2023
      Avg closing price $249.56
      Price range $218.65 - $271.46
      Increased shares by 173.1% (+22.8k shares) Q2 2023
      Avg closing price $232.04
      Price range $214.27 - $253.37
      Sold 91.0% shares (-134k shares) Q1 2023
      Avg closing price $245.47
      Price range $225.79 - $275.20
      New holding (+147k shares) Q4 2022
      Avg closing price $268.06
      Price range $229.03 - $292.39

      News about AMGEN Inc. and Jefferies Group

      Lung Cancer Drugs Global Market is Projected to Increase Revenues Growth, Business Insights, Future Demand and Forecast 2024-2033 | Novartis AG, Pfizer Inc., Menarini Group, AstraZeneca PLC, Amgen Inc.

      Lung Cancer Drugs Global Market is Projected to Increase Revenues Growth, Business Insights, Future Demand and Forecast 2024-2033 | Novartis AG, Pfizer Inc., Menarini Group, AstraZeneca PLC, Amgen Inc.

      "The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extend...

      OpenPR OpenPR, about 1 year ago
      Durex Owner Reckitt Benckiser Taps Into China''s Livestreaming Trend To Sell Condoms Online

      Durex Owner Reckitt Benckiser Taps Into China''s Livestreaming Trend To Sell Condoms Online

      Reckitt Benckiser Group (OTC: RBGLY ) (OTC: RBGPF ) is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challe...

      Benzinga Benzinga, over 1 year ago
      Kades & Cheifetz LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

      Kades & Cheifetz LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

      ¡­ 237,000. Other large investors have also recently made changes ¡­ last quarter. Charles Schwab Investment Management Inc. increased its ¡­ quarter. Finally, ...

      EIN News Investing EIN News Investing, over 1 year ago
      Everhart Financial Group Inc. Purchases 409 Shares of Amgen Inc. (NASDAQ:AMGN)

      Everhart Financial Group Inc. Purchases 409 Shares of Amgen Inc. (NASDAQ:AMGN)

      Everhart Financial Group Inc. lifted its ¡­ during the quarter. Everhart Financial Group Inc.¡¯s holdings in ¡­ on Wednesday, November 1st. Jefferies Financial ...

      EIN News Finance EIN News Finance, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×